Clinical Remission in Severe T2‐High Asthma in Real Life After Anti‐IgE, Anti‐IL‐5 and Anti‐IL5R: A Potential Role for CRP as a Biomarker

ABSTRACT Background Biotherapies have transformed the management of severe asthma (SA), shifting treatment goals from disease control toward achieving clinical remission. This study aimed to evaluate the effectiveness of biotherapies in inducing remission in severe asthma and to identify baseline pa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jeanne Vervier, Marie Sabbe, France Louis, Catherine Moermans, Françoise Guissard, Carole Sanchez, Virginie Paulus, Monique Henket, Genevieve Philippe, Casper W. H. Beijnink, Pierre‐Olivier Bridevaux, Florence Schleich, Renaud Louis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-04-01
Colecção:	Clinical and Translational Allergy
Assuntos:	biologics biomarkers CRP severe asthma
Acesso em linha:	https://doi.org/10.1002/clt2.70164
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!